NOVARTIS AG 13D and 13G filings for MorphoSys AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 4:01 pm Purchase | 2024-10-15 | 13D | MorphoSys AG MOR | NOVARTIS AG | 37,716,423 100.000% | 2,108,003 (+5.92%) | Filing |
| 2024-08-15 4:30 pm Purchase | 2024-08-13 | 13D | MorphoSys AG MOR | NOVARTIS AG | 35,608,420 94.550% | 1,270,611 (+3.70%) | Filing |
| 2024-06-21 4:30 pm Unchanged | 2024-06-19 | 13D | MorphoSys AG MOR | NOVARTIS AG | 34,337,809 91.170% | 0 (Unchanged) | Filing |
| 2024-06-17 4:30 pm Purchase | 2024-06-16 | 13D | MorphoSys AG MOR | NOVARTIS AG | 34,337,809 91.170% | 641,331 (+1.90%) | Filing |
| 2024-06-10 4:30 pm Purchase | 2024-06-06 | 13D | MorphoSys AG MOR | NOVARTIS AG | 33,696,478 89.470% | 3,725,565 (+12.43%) | Filing |
| 2024-05-28 4:30 pm Purchase | 2024-05-23 | 13D | MorphoSys AG MOR | NOVARTIS AG | 29,970,913 79.580% | 25,610,813 (+587.39%) | Filing |
| 2024-04-18 2:33 pm Purchase | 2024-04-12 | 13D | MorphoSys AG MOR | NOVARTIS AG | 4,360,100 11.560% | 4,360,100 (New Position) | Filing |